
USFDA APPLICATION NUMBER - 16964 / DOSAGE - INJECTABLE;INJECTION - 0.5%;0.0091MG/ML
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| Bupivacaine Hydrochloride(UNII: 7TQO7W3VT8) (Bupivacaine - UNII:Y8335394RO) | Bupivacaine Hydrochloride | 5mg in 1 |
Inactive Ingredients
| Ingredient Name | General Injectables & Vaccines, Inc. | Hospira, Inc. | Cardinal Health | RX PHARMA-PACK, INC. | A-S Medication Solutions | A-S Medication Solutions LLC | REMEDYREPACK INC. | Terrain Pharmaceuticals | REMEDYREPACK INC. |
|---|---|---|---|---|---|---|---|---|---|
| ASCORBIC ACID(PQ6CK8PD0R) | |||||||||
| CITRIC ACID MONOHYDRATE(2968PHW8QP) | |||||||||
| EDETATE CALCIUM DISODIUM(25IH6R4SGF) | |||||||||
| HYDROCHLORIC ACID(QTT17582CB) | |||||||||
| METHYLPARABEN(A2I8C7HI9T) | |||||||||
| MONOTHIOGLYCEROL(AAO1P0WSXJ) | |||||||||
| NONOXYNOL-9(48Q180SH9T) | |||||||||
| SODIUM CHLORIDE(451W47IQ8X) | |||||||||
| SODIUM HYDROXIDE(55X04QC32I) | |||||||||
| SODIUM LACTATE(TU7HW0W0QT) | |||||||||
| SODIUM METABISULFITE(4VON5FNS3C) | |||||||||
| SODIUM PHOSPHATE, DIBASIC(GR686LBA74) | |||||||||
| WATER(059QF0KO0R) |